Tevogen Bio Holdings (TVGN) Non-Current Assets (2021 - 2026)

Tevogen Bio Holdings has reported Non-Current Assets for 6 years, with the latest figure at $2.8 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets rose 179.29% year-over-year to $2.8 million; the trailing twelve-month figure through Mar 2026 stood at $10.2 million (up 174.18% YoY), and the FY2025 full-year result was $2.8 million, up 158.29% from the prior year.
• Non-Current Assets for Q1 2026 stood at $2.8 million, down from $2.8 million in the prior quarter.
• The five-year high for Non-Current Assets was $356.9 million in Q4 2022, with the low at $761755.0 in Q3 2024.
• Historically, Non-Current Assets has averaged $88.9 million across 5 years, with a median of $2.8 million in 2025.
• Annual changes were most pronounced in 2023 — Non-Current Assets sank 98.94% — and 2025, when it soared 211.38%.
• Tevogen Bio Holdings' Non-Current Assets stood at $356.9 million in 2022, then slumped by 98.94% to $3.8 million in 2023, then sank by 70.9% to $1.1 million in 2024, then surged by 158.29% to $2.8 million in 2025, then slipped by 2.22% to $2.8 million in 2026.
• The last three Non-Current Assets figures came in at $2.8 million (Q1 2026), $2.8 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.